Castle Biosciences Inc. CBl-2019-SLNBprosp-001: DecisionDx-Melanoma Impact on Sentinel Lymph Node Biopsy Decisions and Clinical Outcomes DECIDE,
Role: Investigator,
Castle Biosciences, Inc.,
(11/2020)
Status: Approved
Internal
Investigator Initiated: A phase II trial of preoperative chemotherapy (with gemcitabine and nab-paclitaxel) and stereotactic body radiotherapy followed by surgery and chemotherapy in patients with resectable pancreatic adenocarcinoma,
Role: Investigator,
LLU Dept. of Surgery,
(09/2025 - 09/2026)
Status: Approved
Cancer care and surgical training in Africa: A needs assessment across the Pan-African Academy of Christian Surgeons (PAACS) and College of Surgeons of East, Central, and Southern Africa (COSECSA) general surgery residencies,
Role: Investigator,
LLU Dept. of Surgery,
(10/2021 - 10/2023)
Status: Approved
Does preoperative biopsy of retroperitoneal and extremity sarcoma change treatment strategy?,
Role: Investigator,
LLU Dept. of Surgery,
(09/2020)
Status: Approved
Gastric and Esophageal cancer databank: Retrospective,
Role: Investigator,
LLU Dept. of Surgery,
(11/2019)
Status: Approved